Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of finerenone in adults with type 1 diabetes and chronic kidney disease
CTR20240105Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finerenone in diabetes mellitus type 1 (T1D), chronic kidney disease (CKD), sponsored by Bayer. Started Jan 2024; status: completed.
02
Drugs
finerenone
03
Conditions
diabetes mellitus type 1 (T1D)chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20240105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240105.